Table 2.
1. | Patient referred to study physician |
2. | Patient consent obtained |
3. | Screening Assessment 1: medical history, supplemental oxygen use and physical exam |
4. | Determine if patient meets eligibility criteria |
5. | Screening Assessment 2: electrocardiogram, spirometry, plethysmography, DLco, 6 MWT, Computed Tomography Scan, PaO2, PaCO2, arterial saturation, continine level, alpha-1 antitrypsin concentration |
6. | Determine if patient continues to meet eligibility criteria |
7. | Patient enters and completes pulmonary rehabilitation program |
8. | Baseline measurements taken: medications, supplemental oxygen use, physical exam, electrocardiogram, spirometry, plethysmography, DLco, 6 MWT, cycle ergometry, quality of life surveys, chest x-ray, ventilation/perfusion (V/Q) scan, PaO2, PaCO2, arterial saturation, blood electrolytes, liver profile, renal profile, CBC, pregnancy test (where appropriate), and continine level |
9. | Final determination of patient eligibility |
10. | Randomization to Control or Treatment arm of the VENT study. |
Abbreviations: DLco = diffusion of the lung for carbon monoxide, 6 MWT = six minute walk test, PaO2 = arterial pressure of oxygen, PaCO2 = arterial pressure of carbon dioxide, CBC = complete blood count.